Read + Share
Amedeo Smart
Independent Medical Education
Zhang Y, Zhou H, Jiang Z, Wu D, et al. Safety and efficacy of jaktinib in the treatment of Janus kinase inhibitor-naive patients with myelofibrosis: Results of a phase II trial. Am J Hematol 2022;97:1510-1519.PMID: 36054786
Email
LinkedIn
Facebook
Twitter
Privacy Policy